Great @TheACMG session today: “The New Era of Genomic Oncology”
All-star cast of speakers including @PughLab & standing room only in one of the main conference ballrooms!
I presented on “Novel Approaches to Cancer Profiling and Treatment Response Prediction Using Cell-Free DNA”
Exciting new research in advanced melanoma shows sequencing T-cells can help predict and monitor response to adoptive cell transfer, a treatment using a patient’s own immune cells to attack cancer. Led by @PughLab & @MarcusButler_PM@UHN@pmcancercentre.
https://t.co/Nw0iMGbMZt
🌟New Resource article
Read about the pancancer landscape of cancer-specific cell-free DNA methylation and fragmentomic features from plasma samples from 1,294 patients
✒️Yong Zeng, @MatLupien, @PughLab, Housheng Hansen He & colleagues
https://t.co/niJ57sU9N2
I'm happy to share this free link to our new paper on the perils of trying to find microbes in human cancers, which appeared today in @NatureCancer. Co-authors include Nobel laureate @barjammar and ancient DNA expert Eske Willerslev: https://t.co/grpN52GrpQ
Trevor Pugh (@PughLab), Brian Crompton (@bdcrompton), Paul Northcott, and Kara Maxwell (@KMaxwellLab) are developing an accurate, accessible blood test for patients with very high inherited cancer risk due to conditions such as Li-Fraumeni Syndrome. 🧬
Registration is OPEN! 🧬 Join the CGC on January 27th for an essential webinar: "Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma."
🗓 Date: Tuesday, Jan 27, 2026 🕐 Time: 1:00 PM – 2:00 PM ET
The Cancer Genomics Consortium (CGC) is looking for dedicated CGC members to join our newest Working Group: Clinical Implementation of Multimodal Liquid Biopsy Cancer Testing. Click here to apply: https://t.co/hTSYCv2IoF
#CGCVolunteers#genomics#cancer#research#genetics
Registration Now Open: The Cancer Genomics Consortium (CGC) invites you to attend Circulating Tumor DNA as Diagnostic Tool in Oncology on December 11, 2025. Click here to register: https://t.co/Y3OTC8PHrs
#CGCVolunteers#genomics#cancer#research#genetics#clinicaltesting
🚨 Excited to chair the AI Applications in Human Health session at the MAQC 8th Annual Conference to make AI clinically relevant and reproducible.
Transparency and reproducibility aren’t optional, they’re the foundation for trustworthy AI in healthcare.
https://t.co/CdCVTFCZn8
Join us next week for "Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing" on October 28, 2025. Click here to learn more and register today: https://t.co/QKS7vQf4iF
Don't miss out! The new letter from the CGC President is here, sharing the latest vision and updates for the future of the Cancer Genomics Consortium. Read the full message now: https://t.co/2xewdF0amW
Honoured to be featured in Open Access Government!
I shared how AI and biomarker discovery are transforming precision oncology, and why rethinking therapy response evaluation is essential to deliver truly personalized cancer care.
Read more 👉 https://t.co/ieG1hGVsPl
Cancer Biology, Early Detection, and ctDNA:
Meredith Irwin, Paul Northcott, Trevor Pugh, Loretta Lau, and Lea Surrey addressed this topic in a plenary session at the AACR Conference on Pediatric Cancer Research. #AACRpediatric25@DrMeredithIrwin@PughLab
Hey TeamUHN! Look up tonight!☝️
The CN Tower will be lit blue and red for UHN's Week of Gratitude — a city-wide thank you to those who deliver remarkable care, research, and education. 💙❤️
Say thank you at: https://t.co/i6pYE7mJ2c!
This. Is. What. Makes. Biotech. Great!
“Regeneron’s relentless pursuit of science and use of proprietary technologies to improve the lives of people with debilitating and life-threatening diseases, no matter their prevalence.” https://t.co/RPDcWqBcvX